KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Revenue (2017 - 2026)

Cardlytics filings provide 10 years of Revenue readings, the most recent being $34.3 million for Q1 2026.

  • Quarterly Revenue fell 39.19% to $34.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $205.7 million through Mar 2026, down 23.0% year-over-year, with the annual reading at $233.3 million for FY2025, 16.18% down from the prior year.
  • Revenue hit $34.3 million in Q1 2026 for Cardlytics, down from $56.1 million in the prior quarter.
  • Across five years, Revenue topped out at $89.2 million in Q4 2023 and bottomed at $34.3 million in Q1 2026.
  • Average Revenue over 5 years is $67.5 million, with a median of $67.9 million recorded in 2022.
  • The largest annual shift saw Revenue rose 28.12% in 2022 before it tumbled 39.19% in 2026.
  • Cardlytics' Revenue stood at $82.5 million in 2022, then rose by 8.08% to $89.2 million in 2023, then dropped by 17.01% to $74.0 million in 2024, then decreased by 24.19% to $56.1 million in 2025, then crashed by 38.82% to $34.3 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Revenue are $34.3 million (Q1 2026), $56.1 million (Q4 2025), and $52.0 million (Q3 2025).